DHTKD1 and Insulin resistance: Ability of adipoyl phosphonate to specifically regulate the DHTKD1-encoded protein in vivo may be useful to develop combinatorial therapies correcting pathological states associated with changed DHTKD1 expression, among which are insulin resistance, obesity, and cancer.